Biotechnology stocks are not out of the woods as far as the medium-term goes, but near-term some promising bases have been formed, lows continue go get bought. It may not be a time to go all out in on the long side, but blindly shorting this ain’t high probability trading either.
Serge Berger
TheSteadyTrader.com
